1 yrCN 3/3 Matches all $2.20-3.50 Min
Tirzepatide reduced initial weight by 15% (5 mg), 19.5% (10 mg), and 20.9% (15 mg), compared to 3.1% in the placebo group, after 72 weekly injections (Jastreboff et al., 2022)
Additionally, ensure the product is third-party tested for purity and free from synthetic fillers, GMOs, and artificial colors
The FDA warning letter from February 20, 2026 cited misleading marketing language, not an unsafe product, but it is a documented compliance issue patients should factor into their decision
Users typically experience reductions in waist circumference, improved metabolic markers, more stable energy levels throughout the day, and better exercise performance and recovery
Approval of the higher dose was based on the findings of the STEP UP clinical trial, results of which were published in November 2025